Transforming How the World Makes Chemicals
Innovative Bio-Based Specialty Chemicals for a Healthier Future
At DMC Biotechnologies, we are revolutionizing the specialty chemical industry by offering sustainable, bio-based ingredients that meet the highest standards of safety, health, and environmental responsibility.
Our pioneering Dynamic Metabolic Control™ technology delivers reliable, cost-effective, and scalable products to meet the growing demands of the market.
OUR PRODUCTS
Our first generation of products showcases the power of our technology platform to produce sustainable, affordable chemicals for a wide range of markets. With a strong pipeline of innovative products already in place and more in development, we are actively transforming the landscape of sustainable chemical production.
DIETARY SUPPLEMENTS & NUTRACEUTICALS
COSMETIC ACTIVES
BIO-BASED CHEMICALS & MONOMERS
COLLABORATING WITH DMC
Go from concept to commercial faster with our standardized, scalable, and proven technology platform that’s Made to Scale™.
DEVELOPMENT
EFFICIENCY
Go from concept to commercial faster with our standardized, scalable, and proven technology platform.
SUSTAINABLE
PRODUCTION
Our L-alanine production may be able to reduce CO2 emissions by over 90%, compared to conventional supply chains. That’s equivalent to removing more than 60,000 cars from the road, annually.
SUPPLY CHAIN
SECURITY
Cost-competitive, local production using agricultural feedstocks enables our customers to diversify their supply chain, making them more resilient to the next global shift.
PARTNER WITH DMC ON YOUR NEXT PRODUCT
DMC’s innovative technology and metabolic engineering expertise enables a broad range of bio-based chemicals to be commercialized rapidly and produced cost-effectively through precision fermentation.
RECENT NEWS
DMC Biotechnologies, Inc. Announces First Close of $1.75M Equity Financing Led by Leuven (Belgium) based Capricorn Venture Partners
09 January 2018 – DMC (www.dmcbio.com), an early-stage biotechnology company, announced today that is has raised a first equity financing led by Capricorn Venture Partners. The company also announced the addition to its Board of Directors of Rob van der Meij,...
DMC & Duke Receive NSF STTR Phase 1 Award
STTR Phase I: Commercialization of Synthetic Metabolic Valves Award Information Agency: National Science Foundation Branch: N/A Contract: 1549624 Agency Tracking Number: 1549624 Amount: $225,000.00 Phase: Phase I Program: STTR Solicitation Topic Code: BT Solicitation...
DMC & Duke Receive NSF STTR Phase 1B Award
Award Abstract #1549624 STTR Phase I: Commercialization of Synthetic Metabolic Valves NSF Org: IIP Div Of Industrial Innovation & Partnersh Initial Amendment Date: December 18, 2015 Latest Amendment Date: December 23, 2016 Award Number: 1549624 Award Instrument:...
Duke and DMC Receive DOE Award for Innovative Bioenergy R&D
DOE Announces $10 Million for Innovative Bioenergy Research and Development The U.S. Department of Energy announced up to $10 million in funding for six projects representing innovative technologies and solutions to advance bioenergy development. These projects,...
INVESTORS
